Eli Lilly and Company
Form 483 issued November 26, 2024 · Concord, North Carolina
- Inspection
- Nov 18 – Nov 26, 2024
- Observations
- 1
- Pages
- 2
- FEI number
- 3027403675
In short: On November 26, 2024, FDA issued a Form 483 with 1 observation to Eli Lilly and Company in Concord, North Carolina (FEI 3027403675) after an inspection that ran Nov 18 – Nov 26, 2024. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.63 (equipment design, size, and location).
At a glance
1 of 1 observations on this 483 concern facilities & equipment.
Most cited: 21 CFR 211.63 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…
This inspection in context
Questions about this 483
What did FDA find at Eli Lilly and Company?
FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.63 (equipment design, size, and location). The opening words of each observation are shown on this page.
When was Eli Lilly and Company inspected by FDA?
The inspection ran Nov 18 – Nov 26, 2024, and the Form 483 is dated November 26, 2024.
How do I get the full Form 483 for Eli Lilly and Company?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.